GBP1 and glioblastoma: In glioblastoma, GBP1’s EGFR-driven role marks it as a malignancy indicator, detectable near the plasma membrane or in cytoplasmic granules via immunohistochemistry, providing a reliable prognostic tool [16,17,67].